Skip to main content
. 2021 May 6;12:681360. doi: 10.3389/fimmu.2021.681360

Table 1.

Baseline characteristics of 41 patients with newly diagnosed POEMS syndrome.

Baseline N (%) Median (range)
Male 28 (68) NA
Age at diagnosis, years NA 49 (21–70)
Time from symptoms to diagnose, months NA 7 (1-84)
Polyneuropathy 41 (100) NA
ONLS score
 Upper limb NA 1 (0–4)
 Lower limb NA 2 (1–7)
 Overall NA 4 (1–10)
Organomegaly 41 (100) NA
 Lymphadenopathy 38 (93) NA
 Splenomegaly 22 (54) NA
 Hepatomegaly 12 (29) NA
Endocrinopathy 41 (100.0) NA
 Diabetes mellitus 6 (15) NA
 Hypothyroidism 17 (42) NA
 Gynecomastia (Male) 21/28 (75) NA
 Increased ACTH 28/39 (72) NA
M-protein 41 (100.0) NA
 IgAλ 25 (61) NA
 IgAλ + IgGκ 1 (2) NA
 IgAλ + IgMλ 1 (2) NA
 IgGλ 13 (32) NA
 λ 1(2) NA
Skin change 41 (100.0) NA
 Hyperpigmentation 38 (93) NA
 Hemangiomas 33 (81) NA
 White nails 25 (61) NA
 Hypertrichosis 15 (37) NA
 Acrocyanosis 6 (15) NA
 Dry skin and ichthyosis-like lesions 9 (22) NA
Bone lesion 31 (76) NA
Extravascular overload 40 (98) NA
 Edema 39 (95) NA
 Ascites 17 (42) NA
 Pleural effusion 21 (51) NA
 Periscardial effusion 28 (68) NA
Serum VEGF, pg/ml 40 (98) 5155 (534–14328)
Pulmonary hypertension, % 3 (7) 54 (51–93)
Papilledema 23 (56) NA
Erythrocytosis 8 (20) 138 (94–182)
Thrombocytosis 18 (44) 332 (89–628)

NA, not available; ONLS, overall neuropathy limitation scale; ACTH, adrenocorticotropic hormone; VEGF, vascular endothelial growth factor.